Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice

Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma

Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand

Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28

What’s the place of immunotherapy in malignant mesothelioma treatments?

Presentation of tumour antigens by dendritic cells and challenges faced

Dendritic cell vaccines for brain tumors

Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies